Showing results (781-790 of 1,073) with videos related to
Sort By:
Pageof 108
Blood Advances|May 1, 2025
Brentuximab Vedotin and Nivolumab for Untreated Patients with Hodgkin Lymphoma: Long-term ResultsBruce David Cheson, Nancy L Bartlett, Betsy Knopf, et al.Disease Models & Mechanisms|September 15, 2019
mTOR hyperactivity mediates lysosomal dysfunction in Gaucher's disease iPSC-neuronal cellsRobert A Brown, Antanina Voit, Manasa P Srikanth, et al.Journal of Empirical Research on Human Research Ethics : JERHRE|March 15, 2019
Variability in Institutional Board Review for a Multisite Assessment of Resident ProfessionalismJudith A Linden, Jeffrey I Schneider, Andrea Cotter, et al.Public Health Action|February 19, 2019
A low cost, re-usable electricity-free infant warmer: evaluation of safety, effectiveness and feasibiliyE Nahimana, L May, A Gadgil, et al.Pediatric Neurology|August 1, 2006
Periventricular hemorrhagic infarction: risk factors and neonatal outcomeHaim Bassan, Henry A Feldman, Catherine Limperopoulos, et al.Neuroimage|September 17, 2022
Quantification of sulcal emergence timing and its variability in early fetal life: Hemispheric asymmetry and sex differenceHyuk Jin Yun, Hyun Ju Lee, Joo Young Lee, et al.Ticks and Tick-Borne Diseases|November 14, 2015
Testing practices and volume of non-Lyme tickborne diseases in the United StatesNeeta P Connally, Alison F Hinckley, Katherine A Feldman, et al.Physical Review Letters|January 24, 2015
Atomic clock with 1×10(-18) room-temperature blackbody Stark uncertaintyK Beloy, N Hinkley, N B Phillips, et al.The Lancet. Haematology|October 4, 2020
Brentuximab vedotin plus nivolumab as first-line therapy in older or chemotherapy-ineligible patients with Hodgkin lymphoma (ACCRU): a multicentre, single-arm, phase 2 trialBruce D Cheson, Nancy L Bartlett, Betsy LaPlant, et al.British Journal of Haematology|April 1, 1987
Studies on the effect of heat treatment on the thrombogenicity of factor IX concentrates in dogsJ D Littlewood, J Dawes, J K Smith, et al.Pageof 108